Results 161 to 170 of about 6,741,320 (294)
Efficacy and Safety of Yiqi Traditional Chinese Medicine Injections for Chronic Pulmonary Heart Disease: A Systematic Review With Pairwise Meta-Analyses and Indirect Comparisons. [PDF]
Yue H, Chai J, Liao H, Jia Y, Wang P.
europepmc +1 more source
A viral luminogenic reporter with chemiluminescence/fluorescence dual‐response and efficient renal clearance was developed for non‐invasive imaging and urinalysis of H1N1 virus protease, allowing for remote detection of H1N1 virus infections and monitoring of antiviral therapeutic efficacy in living mice.
Bankang Ruan +9 more
wiley +1 more source
Comprehensive evidence mapping of Chinese medicine for the treatment of pulmonary heart disease: A systematic assessment of efficacy and challenges. [PDF]
Wang Y, Fu J, Zhao C, Zhang B, Zhou Y.
europepmc +1 more source
A rigid‑flexible integrated CO depot is engineered by embedding rigid COFQDs into a flexible ECM gel network. The rigid framework enables high‑capacity CO storage and sonodynamic bacterial killing, while the flexible ECM gel controls sustained CO release, collectively eradicating multidrug‑resistant infection and promoting scarless healing.
Baohong Sun +13 more
wiley +1 more source
The influencing factors of chronic obstructive pulmonary disease concomitant with pulmonary heart disease and the diagnostic value of myocardial markers. [PDF]
Sun J, Yang T, Sheng Y.
europepmc +1 more source
This study unveils a novel antibacterial mechanism against MRSA, in which the compound Py‐27 selectively targets and inhibits aspartate transcarbamoylase (ATCase), a key enzyme in pyrimidine synthesis. This inhibition disrupts DNA replication, induces oxidative damage, leading to potent bactericidal activity.
Xiaorong Yang +11 more
wiley +1 more source
Establishment and effectiveness of a community self-management intervention model for patients with chronic pulmonary heart disease: A prospective observational study. [PDF]
Cheng S +8 more
europepmc +1 more source
Resolution pharmacology is an emerging strategy to tackle inflammatory pathologies. Bioinspired meroterpenoids induce a lipid mediator class switch toward inflammation resolution in vitro and in vivo by targeting key nodes in lipid mediator biosynthesis and neutral lipid dynamics.
Lorenz Waltl +20 more
wiley +1 more source
Jack Griffiths +7 more
doaj +1 more source

